A Comparative Analysis of Effectiveness of Recombinant Interleukin-11 Versus Papaya Leaf Extract for Treatment of Thrombocytopenia: A Review

Overview

Journal Indian J Clin Biochem

Specialty Biochemistry

Date 2023 May 26

PMID 37234180

Authors

K P Mishra

Jyotsana Bakshi

Gitika Sharma

Somnath Singh

Usha Panjwani

Affiliations

Soon will be listed here.

Abstract

Platelets or thrombocytes play an important role in thrombosis and maintaining hemostasis. Thrombocytes help in forming blood clots at the site of the wound. When the level of platelets decreases, uncontrolled bleeding occurs which can result in mortality. A decrease in the blood platelet level is known as thrombocytopenia which can be caused due to various reasons. A variety of treatment options are available for thrombocytopenia like platelet transfusion, splenectomy, platelet management with various types of corticosteroids, and recombinant interleukin-11 (rhIL-11). The use of rhIL-11 is approved by FDA for the treatment of thrombocytopenia. rhIL-11 is a recombinant cytokine that is administered to patients suffering from chemotherapy-induced thrombocytopenia as it enhances megakaryocytic proliferation which aids in platelet production. But this treatment has various side effects and is costly. Hence, there is a crucial need to identify cost-effective alternative strategies that present no side effects. The majority of the population in low-income countries requires a functional and cost-effective treatment for low thrombocyte count. is a tropical herbaceous plant that has been reported in recovering low platelet count during dengue virus infection. Even though multiple benefits of the leaf extract (CPLE) are popular, the active compound present in it, which mediates these benefits, remains to be identified. This review aims to highlight the different aspects of rhIL-11 and CPLE-induced platelet counts and their limitations and benefits in the treatment of thrombocytopenia. The literature related to the treatment of thrombocytopenia using rhIL-11 and CPLE from 1970 to 2022 was searched using PubMed and Google Scholar databases with the keywords Recombinant Interleukin-11, Papaya Leaf Extract, Thrombocytopenia, and Platelets.

References

Wan B, Zhang H, Fu H, Chen Y, Yang L, Yin J . Recombinant human interleukin-11 (IL-11) is a protective factor in severe sepsis with thrombocytopenia: A case-control study. Cytokine. 2015; 76(2):138-143. DOI: 10.1016/j.cyto.2015.08.001. View

Senthilvel P, Lavanya P, Kumar K, Swetha R, Anitha P, Bag S . Flavonoid from Carica papaya inhibits NS2B-NS3 protease and prevents Dengue 2 viral assembly. Bioinformation. 2013; 9(18):889-95. PMC: 3842573. DOI: 10.6026/97320630009889. View

Sharma N, Mishra K, Chanda S, Bhardwaj V, Tanwar H, Ganju L . Evaluation of anti-dengue activity of Carica papaya aqueous leaf extract and its role in platelet augmentation. Arch Virol. 2019; 164(4):1095-1110. DOI: 10.1007/s00705-019-04179-z. View

Kaur G, Jalagadugula G, Mao G, Rao A . RUNX1/core binding factor A2 regulates platelet 12-lipoxygenase gene (ALOX12): studies in human RUNX1 haplodeficiency. Blood. 2010; 115(15):3128-35. PMC: 2858475. DOI: 10.1182/blood-2009-04-214601. View

Wu S, Zhang Y, Xu L, Dai Y, Teng Y, Ma S . Multicenter, randomized study of genetically modified recombinant human interleukin-11 to prevent chemotherapy-induced thrombocytopenia in cancer patients receiving chemotherapy. Support Care Cancer. 2011; 20(8):1875-84. DOI: 10.1007/s00520-011-1290-x. View

Bhatia M, Davenport V, Cairo M . The role of interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with solid tumors, lymphoma, acute myeloid leukemia and bone marrow failure syndromes. Leuk Lymphoma. 2007; 48(1):9-15. DOI: 10.1080/10428190600909115. View

Nandini C, Madhunapantula S, Bovilla V, Ali M, Mruthunjaya K, Santhepete M . Platelet enhancement by Carica papaya L. leaf fractions in cyclophosphamide induced thrombocytopenic rats is due to elevated expression of CD110 receptor on megakaryocytes. J Ethnopharmacol. 2021; 275:114074. DOI: 10.1016/j.jep.2021.114074. View

Aruoma O, Hayashi Y, Marotta F, Mantello P, Rachmilewitz E, Montagnier L . Applications and bioefficacy of the functional food supplement fermented papaya preparation. Toxicology. 2010; 278(1):6-16. DOI: 10.1016/j.tox.2010.09.006. View

Srikanth B, Reddy L, Biradar S, Shamanna M, Mariguddi D, Krishnakumar M . An open-label, randomized prospective study to evaluate the efficacy and safety of leaf extract for thrombocytopenia associated with dengue fever in pediatric subjects. Pediatric Health Med Ther. 2019; 10:5-11. PMC: 6340360. DOI: 10.2147/PHMT.S176712. View

10.

Zunjar V, Dash R, Jivrajani M, Trivedi B, Nivsarkar M . Antithrombocytopenic activity of carpaine and alkaloidal extract of Carica papaya Linn. leaves in busulfan induced thrombocytopenic Wistar rats. J Ethnopharmacol. 2016; 181:20-5. DOI: 10.1016/j.jep.2016.01.035. View

11.

Chinnappan S, Ramachandrappa V, Tamilarasu K, Krishnan U, Balakrishna Pillai A, Rajendiran S . Inhibition of Platelet Aggregation by the Leaf Extract of Carica papaya During Dengue Infection: An In Vitro Study. Viral Immunol. 2016; 29(3):164-8. DOI: 10.1089/vim.2015.0083. View

12.

Warkentin T . High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: a review. Expert Rev Hematol. 2019; 12(8):685-698. DOI: 10.1080/17474086.2019.1636645. View

13.

Irshad S, Shabbir A, Aslam H, Akhtar T, Shahzad M . Carica papaya ameliorates thrombocytopenia through upregulation of Interleukin-11 and modulation of thrombopoietin in mouse model of carboplatin-induced myelosuppression. Mol Biol Rep. 2022; 49(6):4633-4641. DOI: 10.1007/s11033-022-07311-6. View

14.

Vadhan-Raj S . Management of chemotherapy-induced thrombocytopenia: current status of thrombopoietic agents. Semin Hematol. 2009; 46(1 Suppl 2):S26-32. DOI: 10.1053/j.seminhematol.2008.12.007. View

15.

Guzman M, Halstead S, Artsob H, Buchy P, Farrar J, Gubler D . Dengue: a continuing global threat. Nat Rev Microbiol. 2010; 8(12 Suppl):S7-16. PMC: 4333201. DOI: 10.1038/nrmicro2460. View

16.

Dharmarathna S, Wickramasinghe S, Waduge R, Rajapakse R, Kularatne S . Does Carica papaya leaf-extract increase the platelet count? An experimental study in a murine model. Asian Pac J Trop Biomed. 2013; 3(9):720-4. PMC: 3757281. DOI: 10.1016/S2221-1691(13)60145-8. View

17.

Lei W, Liang J, Chen W, Ma X, Xu M, Du L . [Effectiveness and safety of recombinant human interleukin-11 in the treatment of chemotherapy-induced thrombocytopenia]. Zhonghua Zhong Liu Za Zhi. 2006; 28(7):542-4. View

18.

Tepler I, Elias L, Smith 2nd J, Hussein M, Rosen G, Chang A . A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy. Blood. 1996; 87(9):3607-14. View

19.

Opal S, Keith Jr J, Jhung J, Palardy J, Parejo N, Marchese E . Orally administered recombinant human interleukin-11 is protective in experimental neutropenic sepsis. J Infect Dis. 2003; 187(1):70-6. DOI: 10.1086/345864. View

20.

Assinger A . Platelets and infection - an emerging role of platelets in viral infection. Front Immunol. 2015; 5:649. PMC: 4270245. DOI: 10.3389/fimmu.2014.00649. View